Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Sales (2021 - 2022)

Historic Return on Sales for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q3 2022 value amounting to 0.19%.

  • Atea Pharmaceuticals' Return on Sales rose 10400.0% to 0.19% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.19%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.34% for FY2021, which is 5700.0% up from last year.
  • Per Atea Pharmaceuticals' latest filing, its Return on Sales stood at 0.19% for Q3 2022, which was up 10400.0% from 0.07% recorded in Q2 2022.
  • Atea Pharmaceuticals' Return on Sales' 5-year high stood at 0.61% during Q4 2021, with a 5-year trough of 0.86% in Q3 2021.